- House Committee Substitute -

HCS/SB 407 - This act requires health insurance policies to provide coverage for routine patient costs incurred for FDA-approved drugs and devices, regardless of whether the drugs and devices were approved for use in treating the patient's particular condition.

Entities seeking coverage for clinical trials do not have to post electronically whether the trial is for the treatment of cancer or other life-threatening disease.

The HCS removes the phrase "if not cancer".

This act is similar to HB 192 (2003).

LORIE TOWE